Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase

被引:200
作者
Muller, Alexander J. [5 ]
Sharma, Madhav D. [2 ]
Chandler, Phillip R. [1 ]
DuHadaway, James B. [5 ]
Everhart, Mary E. [3 ]
Johnson, Buries A., III [3 ]
Kahler, David J. [3 ]
Pihkala, Jeanene [4 ]
Soler, Alejandro Peralta [5 ]
Munn, David H. [2 ]
Prendergast, George C. [5 ]
Mellor, Andrew L. [1 ]
机构
[1] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA
[2] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA
[3] Immunotherapy & Canc Ctr, Augusta, GA 30912 USA
[4] Flow Cytometry Core Facil, Augusta, GA USA
[5] Lankenau Inst Med Res, Wynnewood, PA 19096 USA
基金
美国国家卫生研究院;
关键词
dendritic cells; T cells; TPA; carcinogenesis; tryptophan;
D O I
10.1073/pnas.0806173105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Topical application of phorbol myristate acetate (PMA) elicits intense local inflammation that facilitates outgrowth of premalignant lesions in skin after carcinogen exposure. The inflammatory response to PMA treatment activates immune stimulatory mechanisms. However, we show here that PMA exposure also induces plasmacytoid dendritic cells (pDCs) in local draining lymph nodes (dLNs) to express indoleamine 2,3 dioxygenase (IDO), which confers T cell suppressor activity on pDCs. The induced IDO-mediated inhibitory activity in this subset of pDCs was potent, dominantly suppressing the T cell stimulatory activity of other DCs that comprise the major fraction of dLN IDCs. IDO induction in pDCs depended on inflammatory signaling by means of IFN type I and II receptors, the TLR/lL-1 signaling adaptor MyD88, and on cellular stress responses to amino acid withdrawal by means of the integrated stress response kinase GCN2. Consistent with the hypothesis that T cell suppressive, IDO+ pDCs elicited by PMA exposure create local immune privilege that favors tumor development, IDO-deficient mice exhibited a robust tumor-resistant phenotype in the standard DMBA/PMA 2-stage carcinogenesis model of skin papilloma formation. Thus, IDO is a key immunosuppressive factor that facilitates tumor progression in this setting of chronic inflammation driven by repeated topical PMA exposure.
引用
收藏
页码:17073 / 17078
页数:6
相关论文
共 42 条
[1]   Quantitation of tryptophan, kynurenine and kynurenic acid in human plasma by capillary liquid chromatography-electrospray ionization tandem mass spectrometry [J].
Amirkhani, A ;
Heldin, E ;
Markides, KE ;
Bergquist, J .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 780 (02) :381-387
[2]   Type I interferon dependence of plasmacytoid dendritic cell activation and migration [J].
Asselin-Paturel, C ;
Brizard, G ;
Chemin, K ;
Boonstra, A ;
O'Garra, A ;
Vicari, A ;
Trinchieri, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) :1157-1167
[3]   A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type IIFN signaling following B7 ligation [J].
Baban, B ;
Hansen, AM ;
Chandler, PR ;
Manlapat, A ;
Bingaman, A ;
Kahler, DJ ;
Munn, DH ;
Mellor, AL .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (07) :909-919
[4]   Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific [J].
Baban, B ;
Chandler, P ;
McCool, D ;
Marshall, B ;
Munn, DH ;
Mellor, AL .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2004, 61 (02) :67-77
[5]   Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice [J].
Ball, Helen J. ;
Sanchez-Perez, Angeles ;
Weiser, Silvia ;
Austin, Christopher J. D. ;
Astelbauer, Florian ;
Miu, Jenny ;
McQuillan, James A. ;
Stocker, Roland ;
Jermiin, Lars S. ;
Hunt, Nicholas H. .
GENE, 2007, 396 (01) :203-213
[6]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[7]   FURTHER GENETIC ANALYSES OF SKIN TUMOR PROMOTER SUSCEPTIBILITY USING INBRED AND RECOMBINANT INBRED MICE [J].
DIGIOVANNI, J ;
IMAMOTO, A ;
NAITO, M ;
WALKER, SE ;
BELTRAN, L ;
CHENICEK, KJ ;
SKOW, L .
CARCINOGENESIS, 1992, 13 (04) :525-531
[8]   The immunobiology of cancer immunosurveillance and immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
IMMUNITY, 2004, 21 (02) :137-148
[9]   Modulation of tryptophan catabolism by regulatory T cells [J].
Fallarino, F ;
Grohmann, U ;
Hwang, KW ;
Orabona, C ;
Vacca, C ;
Bianchi, R ;
Belladonna, ML ;
Fioretti, MC ;
Alegre, ML ;
Puccetti, P .
NATURE IMMUNOLOGY, 2003, 4 (12) :1206-1212
[10]   Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells [J].
Fallarino, F ;
Orabona, C ;
Vacca, C ;
Bianchi, R ;
Gizzi, S ;
Asselin-Paturel, C ;
Fioretti, MC ;
Trinchieri, G ;
Grohmann, U ;
Puccetti, P .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (11) :1429-1438